These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34231823)

  • 41. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
    Camargo CH; Gonçalves CR; Pagnoca EVRG; Campos KR; Montanha JOM; Flores MNP; Soares MMCN; Binhardi FMT; Ferreira PM; Yu ALF; Carvalhanas TRMP; Abbud A; Bugno A; Sacchi CT
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115516. PubMed ID: 34425504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.
    Souza WM; Amorim MR; Sesti-Costa R; Coimbra LD; Brunetti NS; Toledo-Teixeira DA; de Souza GF; Muraro SP; Parise PL; Barbosa PP; Bispo-Dos-Santos K; Mofatto LS; Simeoni CL; Claro IM; Duarte ASS; Coletti TM; Zangirolami AB; Costa-Lima C; Gomes ABSP; Buscaratti LI; Sales FC; Costa VA; Franco LAM; Candido DS; Pybus OG; de Jesus JG; Silva CAM; Ramundo MS; Ferreira GM; Pinho MC; Souza LM; Rocha EC; Andrade PS; Crispim MAE; Maktura GC; Manuli ER; Santos MNN; Camilo CC; Angerami RN; Moretti ML; Spilki FR; Arns CW; Addas-Carvalho M; Benites BD; Vinolo MAR; Mori MAS; Gaburo N; Dye C; Marques-Souza H; Marques RE; Farias AS; Diamond MS; Faria NR; Sabino EC; Granja F; Proença-Módena JL
    Lancet Microbe; 2021 Oct; 2(10):e527-e535. PubMed ID: 34258603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brief dispersion of a putative B.1.1.28-derived SARS-CoV-2 lineage harboring additional N234P and E471Q spike protein mutations in individuals crossing the Argentina-Brazil border.
    Soares da Silva M; Gularte JS; Demoliner M; Hansen AW; Heldt FH; Filippi M; Luckmann CB; Malayhka de Abreu Góes Pereira V; de Almeida Vaucher R; Barboza VDS; Giongo JL; Rosa RB; Tarouco da Rocha E; Goulart BK; Fernandes FDS; Pinto JM; Bolzan LP; Medeiros Frescura Duarte MM; Weber MN; Rodrigues de Almeida P; Fleck JD; Spilki FR
    Travel Med Infect Dis; 2022; 49():102390. PubMed ID: 35753659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021.
    Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK
    Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamics of SARS-CoV-2 Variants of Concern in Brazil, Early 2021.
    Levi JE; Oliveira CM; Croce BD; Telles P; Lopes ACW; Romano CM; Lira DB; de Resende ACM; Lopes FP; Ruiz AA; Campana G
    Front Public Health; 2021; 9():784300. PubMed ID: 35004585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics.
    Franco-Luiz APM; Fernandes NMGS; Silva TBS; Bernardes WPOS; Westin MR; Santos TG; Fernandes GDR; Simões TC; Silva EFE; Gava SG; Alves BM; de Carvalho Melo M; da Silva-Pereira RA; Alves PA; Fonseca CT
    Front Immunol; 2023; 14():1220600. PubMed ID: 37520570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil.
    Lamarca AP; de Almeida LGP; Francisco RDS; Lima LFA; Scortecci KC; Perez VP; Brustolini OJ; Sousa ESS; Secco DA; Santos AMG; Albuquerque GR; Mariano APM; Maciel BM; Gerber AL; Guimarães APC; Nascimento PR; Neto FPF; Gadelha SR; Porto LC; Campana EH; Jeronimo SMB; Vasconcelos ATR
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009835. PubMed ID: 34644287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.
    Park AK; Rhee JE; Kim IH; Kim HM; Lee H; Kim JA; Lee CY; Lee NJ; Woo S; Lee J; No JS; Rhie GE; Wang SJ; Lee SE; Park YJ; Park G; Kim JY; Gwack J; Yoo CK; Kim EJ
    J Med Virol; 2022 Apr; 94(4):1717-1722. PubMed ID: 34862628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 54. SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021.
    Nonaka CKV; Gräf T; Barcia CAL; Costa VF; de Oliveira JL; Passos RDH; Bastos IN; de Santana MCB; Santos IM; de Sousa KAF; Weber TGL; Siqueira IC; Rocha CAG; Mendes AVA; Souza BSF
    Int J Infect Dis; 2021 Oct; 111():47-54. PubMed ID: 34390857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reinfection With SARS-CoV-2: Implications for Vaccines.
    Cohen JI; Burbelo PD
    Clin Infect Dis; 2021 Dec; 73(11):e4223-e4228. PubMed ID: 33338197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing.
    Loconsole D; Sallustio A; Accogli M; Centrone F; Casulli D; Madaro A; Tedeschi E; Parisi A; Chironna M
    Viruses; 2021 May; 13(5):. PubMed ID: 34066205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
    de Siqueira IC; Camelier AA; Maciel EAP; Nonaka CKV; Neves MCLC; Macêdo YSF; de Sousa KAF; Araujo VC; Paste AA; Souza BSF; Gräf T
    Int J Infect Dis; 2021 Jul; 108():252-255. PubMed ID: 33989776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.
    Naveca FG; Nascimento V; de Souza VC; Corado AL; Nascimento F; Silva G; Costa Á; Duarte D; Pessoa K; Mejía M; Brandão MJ; Jesus M; Gonçalves L; da Costa CF; Sampaio V; Barros D; Silva M; Mattos T; Pontes G; Abdalla L; Santos JH; Arantes I; Dezordi FZ; Siqueira MM; Wallau GL; Resende PC; Delatorre E; Gräf T; Bello G
    Nat Med; 2021 Jul; 27(7):1230-1238. PubMed ID: 34035535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.